Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
NAFFIC and Aware to Launch First China-Europe Digital Product Passport - 2Heart disease risk greater for women with a common condition they may not be aware they have
- 3April full moon 2026 dazzles as 'Pink Moon' lights up skies worldwide (photos)
- 4How stripping diversity, equity and inclusion from health care may make Americans sicker
- 5Best bar-b-que Style: Which One Is Your Number one?
- Saudi Arabia says it intercepted 7 missiles, debris falls near energy facilities
- vote in favor of Your #1 kind of climate
- Physicists and philosophers have long struggled to understand the nature of time: Here's why
- Surge of off‑lease electric vehicles expected to drive down used EV prices
- Reveal Less popular Authentic Realities You Didn't Learn in School
- Activists: Venezuela released just nine prisoners despite promise
- I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man.
- Ariana Grande and Jonathan Bailey will reunite for 'Sunday in the Park With George'
- Katz to Hezbollah chief Qassem: You won't live to see Israel’s full response to Passover attacks
